FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044608575> ?p ?o ?g. }

• W2044608575 endingPage "1903" @default.
• W2044608575 startingPage "1893" @default.
• W2044608575 abstract "The treatment of primary biliary cirrhosis (PBC) with conventional immunosuppressive drugs has been relatively disappointing and there have been few efforts in defining a role for the newer biological agents useful in rheumatoid arthritis and other systemic autoimmune diseases. In this study we took advantage of transforming growth factor-β (TGF-β) receptor II dominant negative (dnTGF-βRII) mice, a mouse model of autoimmune cholangitis, to address the therapeutic efficacy of B-cell depletion using anti-CD20. Mice were treated at either 4-6 weeks of age or beginning at 20-22 weeks of age with intraperitoneal injections of anti-CD20 every 2 weeks. We quantitated B-cell levels in all mice as well as antimitochondrial antibodies (AMA), serum and hepatic levels of proinflammatory cytokines, and histopathology of liver and colon. In mice whose treatment was initiated at 4-6 weeks of age, anti-CD20 therapy demonstrated a significantly lower incidence of liver inflammation associated with reduced numbers of activated hepatic CD8+ T cells. However, colon inflammation was exacerbated. In contrast, in mice treated at 20-22 weeks of age, anti-CD20 therapy had relatively little effect on either liver or colon disease. As expected, all treated animals had reduced levels of B cells, absence of AMA, and increased levels in sera of tumor necrosis factor alpha (TNF-α), interleukin 6 (IL-6), and chemokine (C-C motif) ligand (CCL2) (monocyte chemoattractant protein 1 [MCP-1]). Conclusion: These data suggest potential usage of anti-CD20 in early PBC resistant to other modalities, but raise a cautionary note regarding the use of anti-CD20 in inflammatory bowel disease. (HEPATOLOGY 2009.)" @default.
• W2044608575 created "2016-06-24" @default.
• W2044608575 creator A5019715351 @default.
• W2044608575 creator A5025139735 @default.
• W2044608575 creator A5029678899 @default.
• W2044608575 creator A5035953102 @default.
• W2044608575 creator A5045079164 @default.
• W2044608575 creator A5054028955 @default.
• W2044608575 creator A5066151943 @default.
• W2044608575 creator A5066462726 @default.
• W2044608575 creator A5071407810 @default.
• W2044608575 creator A5073399902 @default.
• W2044608575 creator A5080746000 @default.
• W2044608575 creator A5090529676 @default.
• W2044608575 date "2009-08-10" @default.
• W2044608575 modified "2023-10-16" @default.
• W2044608575 title "B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-β receptor II dominant negative mice" @default.
• W2044608575 cites W1513087353 @default.
• W2044608575 cites W1571743853 @default.
• W2044608575 cites W1633176708 @default.
• W2044608575 cites W1646114581 @default.
• W2044608575 cites W1650215555 @default.
• W2044608575 cites W1966337867 @default.
• W2044608575 cites W1987496501 @default.
• W2044608575 cites W1989542315 @default.
• W2044608575 cites W1991065491 @default.
• W2044608575 cites W1995401008 @default.
• W2044608575 cites W2007557866 @default.
• W2044608575 cites W2009193187 @default.
• W2044608575 cites W2010403624 @default.
• W2044608575 cites W2010798754 @default.
• W2044608575 cites W2019392181 @default.
• W2044608575 cites W2019481852 @default.
• W2044608575 cites W2023819715 @default.
• W2044608575 cites W2024447443 @default.
• W2044608575 cites W2024691741 @default.
• W2044608575 cites W2027963480 @default.
• W2044608575 cites W2039347592 @default.
• W2044608575 cites W2039892177 @default.
• W2044608575 cites W2041767278 @default.
• W2044608575 cites W2053064965 @default.
• W2044608575 cites W2056696418 @default.
• W2044608575 cites W2058430881 @default.
• W2044608575 cites W2062264613 @default.
• W2044608575 cites W2069959734 @default.
• W2044608575 cites W2070878729 @default.
• W2044608575 cites W2077690116 @default.
• W2044608575 cites W2084380838 @default.
• W2044608575 cites W2100832209 @default.
• W2044608575 cites W2104087345 @default.
• W2044608575 cites W2121133002 @default.
• W2044608575 cites W2124711796 @default.
• W2044608575 cites W2148082560 @default.
• W2044608575 cites W2162867332 @default.
• W2044608575 cites W2167318411 @default.
• W2044608575 cites W2802290858 @default.
• W2044608575 cites W4292540530 @default.
• W2044608575 doi "https://doi.org/10.1002/hep.23238" @default.
• W2044608575 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4130556" @default.
• W2044608575 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19877182" @default.
• W2044608575 hasPublicationYear "2009" @default.
• W2044608575 type Work @default.
• W2044608575 sameAs 2044608575 @default.
• W2044608575 citedByCount "86" @default.
• W2044608575 countsByYear W20446085752012 @default.
• W2044608575 countsByYear W20446085752013 @default.
• W2044608575 countsByYear W20446085752014 @default.
• W2044608575 countsByYear W20446085752015 @default.
• W2044608575 countsByYear W20446085752016 @default.
• W2044608575 countsByYear W20446085752017 @default.
• W2044608575 countsByYear W20446085752018 @default.
• W2044608575 countsByYear W20446085752019 @default.
• W2044608575 countsByYear W20446085752020 @default.
• W2044608575 countsByYear W20446085752021 @default.
• W2044608575 countsByYear W20446085752022 @default.
• W2044608575 countsByYear W20446085752023 @default.
• W2044608575 crossrefType "journal-article" @default.
• W2044608575 hasAuthorship W2044608575A5019715351 @default.
• W2044608575 hasAuthorship W2044608575A5025139735 @default.
• W2044608575 hasAuthorship W2044608575A5029678899 @default.
• W2044608575 hasAuthorship W2044608575A5035953102 @default.
• W2044608575 hasAuthorship W2044608575A5045079164 @default.
• W2044608575 hasAuthorship W2044608575A5054028955 @default.
• W2044608575 hasAuthorship W2044608575A5066151943 @default.
• W2044608575 hasAuthorship W2044608575A5066462726 @default.
• W2044608575 hasAuthorship W2044608575A5071407810 @default.
• W2044608575 hasAuthorship W2044608575A5073399902 @default.
• W2044608575 hasAuthorship W2044608575A5080746000 @default.
• W2044608575 hasAuthorship W2044608575A5090529676 @default.
• W2044608575 hasBestOaLocation W20446085751 @default.
• W2044608575 hasConcept C126322002 @default.
• W2044608575 hasConcept C159654299 @default.
• W2044608575 hasConcept C164027704 @default.
• W2044608575 hasConcept C17991360 @default.
• W2044608575 hasConcept C18031839 @default.
• W2044608575 hasConcept C203014093 @default.
• W2044608575 hasConcept C2776914184 @default.
• W2044608575 hasConcept C2777575956 @default.

• next